Imricor Medical Systems, Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was USD 0.199 million compared to USD 0.538 million a year ago. Net loss was USD 9.22 million compared to USD 9.78 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.445 AUD | -1.11% | -2.20% | -21.93% |
May. 15 | Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call | |
May. 09 | Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.93% | 60.87M | |
+11.18% | 227B | |
+15.22% | 198B | |
+19.19% | 142B | |
+30.89% | 111B | |
+1.56% | 64.16B | |
+18.48% | 54.1B | |
+5.12% | 51.41B | |
+10.53% | 45.32B | |
+5.98% | 37.32B |
- Stock Market
- Equities
- IMR Stock
- News Imricor Medical Systems, Inc.
- Imricor Medical Systems, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023